ebook Munafa Stock Market Course + Intraday & FNO calls  

       

LLY announcements Eli Lilly And Company announcements and dividends declared USA

Eli Lilly And Company Complete list of announcements declared & dividend announcements by Eli Lilly And Company LLY

Eli Lilly And Company LLY listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Eli Lilly And Company LLY

What's Next For Eli Lilly Stock After A Solid Q4?
Eli Lilly (NYSE: LLY) fourth-quarter performance exceeded the street expectations, with the company delivering adjusted earnings of .32 per share versus the projected .95. Revenue came in at .5 billion, slightly below the consensus estimate of .6
Announcement as on 10 February 2025

Eli Lilly: 4 Reasons Investors Shouldn’t Miss This Opportunity
Eli Lilly & Co. (NYSE: LLY) is a major global pharmaceutical company in the medical sector. The company made headlines with its dominant GLP-1 drug, Tirzepatide, sold as Mounjaro for type 2 diabetes and Zepbound for obesity. While there are many potential
Announcement as on 14 January 2025

US pharma major Eli Lilly and Co plans to establish new GCC in Hyderabad
US pharma company Eli Lilly plans to open a new global capability centre in Hyderabad by mid-2025. It will recruit over 1,000-1500 skilled workers, including technology engineers and data scientists. The centre will focus on expanding capabilities in autom
Announcement as on 09 January 2025

Medicare can cover Zepbound for sleep apnea. There's opportunity for Eli Lilly.

Announcement as on 09 January 2025

Lupin acquires 'Huminsulin' in India from Eli Lilly and Co
Lupin Ltd has acquired the anti-diabetic medicine Huminsulin in India from Eli Lilly to expand its diabetes portfolio. This move aims to provide high-quality, affordable healthcare for diabetes patients. Huminsulin is used for treating Type 1 and Type 2 di
Announcement as on 30 December 2024

Announcements by Eli Lilly And Company first page | Next page | Prev page |

LLY Eli Lilly And Company current price & indicator signals

Moving Averages for Eli Lilly And Company

  • 5Day Average: 1029.4
  • 12Day Average: 1023.99
  • 20Day Average: 1041.39
  • 50Day Average: 941.86
  • 100Day Average: 838.18
  • 150Day Average: 814.09
  • 200Day Average: 814.82

LLY Indicators & signals

Indicator MACD (12,26,9)

1029.6, 1007.24, 28.84
Indicator MACD is in positive zone

Indicator ADX (14)

17.89, 27.56, 19.2
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 60
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of LLY Eli Lilly And Company are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
16 Tue Dec 2025 1054.29 1036.23 to 1068.25 -0.74% 1.28 times
15 Mon Dec 2025 1062.19 1032.55 to 1065.00 3.38% 1.48 times
12 Fri Dec 2025 1027.51 1003.50 to 1028.90 1.8% 1.05 times
11 Thu Dec 2025 1009.38 987.00 to 1031.56 1.58% 1.44 times
10 Wed Dec 2025 993.64 977.12 to 1003.00 1.16% 0.95 times
09 Tue Dec 2025 982.22 979.18 to 1012.00 -1.54% 0.82 times
08 Mon Dec 2025 997.59 988.88 to 1014.20 -1.21% 0.98 times
05 Fri Dec 2025 1009.77 1004.00 to 1027.39 -0.47% 0.41 times
04 Thu Dec 2025 1014.49 1007.18 to 1032.63 -1.85% 1.23 times
03 Wed Dec 2025 1033.56 1022.32 to 1051.48 -1.13% 1.1 times
02 Tue Dec 2025 1045.37 1040.36 to 1068.18 -1.18% 0.54 times
01 Mon Dec 2025 1057.89 1055.00 to 1084.15 -1.63% 0.98 times

Videos related to: LLY announcements Eli Lilly And Company announcements and dividends declared USA

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

LLY announcements Eli Lilly And Company announcements and dividends declared USA

 

Back to top